Better Buy: SpaceX or Nvidia?

The article argues Nvidia is the better buy vs. SpaceX, highlighting that SpaceX is priced far more expensively despite slower growth. SpaceX generated $18.7B revenue in 2025 and, at a ~$1.57T market cap, trades at an estimated ~84x price-to-sales; even a long-term goal of 45% profit margin would imply extremely high valuation (~186x earnings if achieved instantly). By contrast, Nvidia is projected to grow revenue ~82% this year and ~42% next year and trades at ~31x trailing and ~23x forward earnings, leading the author to prefer Nvidia for valuation and growth.

Analysis

The market read-through is less about SpaceX itself and more about which kind of AI exposure gets rewarded: visible earnings today or narrative optionality tomorrow. That usually favors NVDA because incremental capital still wants a proven cash generator with operating leverage, while high-duration platforms get discounted when rates stay sticky or risk appetite cools. The second-order effect is a valuation reset across other “AI-adjacent” private-to-public stories that lack clean unit economics.

SPCX’s supposed diversification is a double-edged sword. Multi-engine stories often deserve a conglomerate discount until investors can separate durable cash flow from cross-subsidized growth, and that discount widens when one segment is still being priced off hope rather than audited profitability. If Starlink monetization or xAI economics do not show up clearly in the next 1-2 reporting cycles, the stock is vulnerable to multiple compression even if top-line growth remains respectable.

Near term, this is primarily a positioning trade, not a fundamental inflection. A bearish SPCX view is falsified if management demonstrates a credible path to materially higher margins or if the market reopens the door to speculative, long-duration assets; otherwise the path of least resistance is lower as investors rotate into cheaper, profitable AI beneficiaries. Watch for any guidance that converts “big market” rhetoric into measurable FCF conversion.

Key Decisions for Investors

• Initiate a 1-3 month pair trade: long NVDA / short SPCX. Thesis is spread compression as capital rotates from expensive narrative exposure into earnings-backed AI leverage; target is 10-15% relative outperformance for NVDA, with the trade invalidated if SPCX shows a clear margin inflection.
• Buy NVDA on weakness rather than chasing SPCX strength. Any pullback tied to broader AI capex fatigue should be viewed as a better entry point for the name with the clearest pass-through from demand to earnings.
• Use rallies in SPCX to build a tactical short, not a full-size structural short. The risk/reward is best when momentum re-prices the IPO above fundamentals; cover if the stock holds key support after the next disclosure or if growth/margin guidance improves materially.
• Set a catalyst watch on SPCX’s next quarterly update: if management does not narrow the gap between revenue growth and margin credibility, expect the discount rate to rise further and the stock to underperform long-duration tech peers.